Get started
BAVARIAN NORDIC A/SBAVARIAN NORDIC A/SBAVARIAN NORDIC A/S

BAVARIAN NORDIC A/S

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

BAVA trade ideas

Monkey Pox vaxBeen tracking cdc data on monkey pox from 1st week of may this year. Cases have gone from 7 to 22k+ today. Their can be much speculation as to why or what this actually will be, but that would be another website. Bavarian Nordic has already received the green light from US and EU to mass produce these vaccines in a Denmark facility. I expect cases to explode, and that we will find out that just about anyone can get this..So these guys are the market. Weekly measured move from the wedge is 160$ area, The 1.618 of the top to low of the formation is right around the same area. I think this gets tagged by year end..Not going to move in a straight line here, absolutely could pull back. However,SanFran, and NYC have already declared a state of emergency as of Yesterday....Always do what you think is best, this is in no way financial advice. GL
OTC:BVNKFLong
by jbcal
$BVNRY PTs 300-400 and higher Bavarian Nordic is the only company with an FDA approved Monkey Pox Vaccine Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
OTC:BVNRYLong
by BADQOMOCAWGOWLD
1
BAVA MonkeyPox VaccineHere we go again...? "The spread of monkeypox boosted the shares of Bavarian Nordic A/S, which says it’s the only company to make a vaccine approved for the viral infection. The Danish company gained as much as 26% in Copenhagen trading on Thursday after saying it had secured a contract to supply its smallpox shot -- which is also cleared against monkeypox -- to an undisclosed European country. Monkeypox, a virus that is endemic in some forested parts of central and west Africa, has been found in a handful of cases in the UK, Spain and Portugal in recent days and in one person in the US. The World Health Organization said Wednesday it was monitoring a situation that 'is evolving rapidly.' " www.bloomberg.com
OMXCOP:BAVALong
by reiiss7
BAVA: a great entrance pointBAVA is moving up in a channel looking at the chart back to april 2020. At the moment it is moving downwards inside this channel, and I think it will continue down below 280 Dkr. But to do so, it needs to break through and downwards from the wedge it is at presently. If it continues below 280 Dkr, it could mean a lot of upside, when it goes the other way towards the upper side of the channel. Disclaimer: I hope I can inspire and entertain, but I am not a financial advisor. Please do your own research.
OMXCOP:BAVALong
by UnknownUnicorn28352024